Document is current
Any future updates will be listed below
-
Authors
Kumar, Sandeep
Ziegler, Yvonne
Plotner, Blake N.
Flatt, Kristen M.
Kim, Sung Hoon
Katzenellenbogen, John A.
Katzenellenbogen, Benita S. https://orcid.org/0000-0002-8847-2752
-
Funding
Funding for this research was provided by:
Breast Cancer Research Foundation (BCRF-083, BCRF-083, BCRF-083, BCRF-083, BCRF-083, BCRF-083)
NIH/NCI (1R01 CA220284, 1R01 CA220284, 1R01 CA220284, 1R01 CA220284)
NIH (R01CA234025, R01CA234025)
The Julius and Mary Landfield Cancer Research Fund
- License Information
-
More Information
Article History
Received: 11 March 2024
Accepted: 27 June 2024
First Online: 9 July 2024
Declarations
:
: BSK, JAK, and SHK are co-inventors on patents filed by the University of Illinois to cover the FOXM1 inhibitor compounds described in this paper. BSK and JAK are members of the Scientific Advisory Board of Celcuity. The other authors declare no competing interests.
: This article does not contain any studies with human participants or involving animals performed by any of the authors.
: Not applicable.
